Apr 15, 2019 Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH)
Feb 19, 2019 Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency